Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Stephen K Doberstein
5 Sep 2019
SVP & Chief Scientific Officer
Buy
15,000
$17.28
$259.20K
Showing 250 of 382 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 431
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 122
Sales at will 212
Transactions with no price 0
Shares from compensation/vesting 10,057,054
Sales filed before the plan box existed 165
History held since 7 Nov 2006